Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AWP R.I.P.? First DataBank, Medi-Span Institute Price Reporting Changes

This article was originally published in The Pink Sheet Daily

Executive Summary

Wholesalers have stopped participating in pricing surveys, so First DataBank is replacing "Blue Book" average wholesale price with alternative benchmark price based on wholesale acquisition cost mark-up. Medi-Span will continue to offer AWP, but will note whether it is based on historical surveys or a standard mark-up.

You may also be interested in...

First DataBank Moving Past AWP, But Will Need Government, Industry Help

Pricing data publisher does not expect to stop publishing “Blue Book” AWPs unless regulatory or industry guidelines lead to better reporting of wholesaler acquisition cost and other prices.

NME Slowdown Shows Market Pressure On Me-Toos, Not FDA Caution – Lutter

DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts